Effects of Molecular Hydrogen on Methamphetamine-Induced Neurotoxicity and Spatial Memory Impairment.
Di Wen, Rongji Hui, Jian Wang, Xi Shen, Bing Xie, Miao Gong, Feng Yu, Bin Cong, Chunling Ma · Frontiers in pharmacology · 2019
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
In mice, aNOVA with percentage of exploration time spent in the target quadrant revealed a significant effect of METH (F (1,31) = 24.930, p < 0.001) and ad libitum HRW consumption treatment (F (1,31) = 6.286, p = 0.018), but no significant effect of the interaction (F (1,31) = 3.291, p = 0.079) between METH and ad libitum HRW consumption treatment. Two-way ANOVA with motion speed revealed no significant effects of METH (F (1,31) = 2.573, p = 0.119), ad libitum HRW consumption (F (1,31) = 0.269, p = 0.608) treatment, and the interaction between these two factors (F (1,31) = 0.578, p = 0.453). These preclinical findings add evidence supporting molecular hydrogen's therapeutic potential within the outcomes and biological pathways measured in this model.
What the Findings Mean
H2HUBB reviewed how hydrogen-rich water affected the outcomes measured in mice. ANOVA with percentage of exploration time spent in the target quadrant revealed a significant effect of METH (F (1,31) = 24.930, p < 0.001) and ad libitum HRW consumption treatment (F (1,31) = 6.286, p = 0.018), but no significant effect of the interaction (F (1,31) = 3.291, p = 0.079) between METH and ad libitum HRW consumption treatment.
What the Researchers Studied
The researchers studied mice. The study used a preclinical animal experiment.
What Effects Did Molecular Hydrogen Have?
Source-reported hydrogen concentration: 2.0 mg/L H₂; reported treatment duration: 7 days. ANOVA with percentage of exploration time spent in the target quadrant revealed a significant effect of METH (F (1,31) = 24.930, p < 0.001) and ad libitum HRW consumption treatment (F (1,31) = 6.286, p = 0.018), but no significant effect of the interaction (F (1,31) = 3.291, p = 0.079) between METH and ad libitum HRW consumption treatment. The authors concluded that these are the first findings to indicate that hydrogen might ameliorate METH-induced neurotoxicity and has a potential application in reducing the risk of neurodegeneration frequently observed in METH abusers. The protective effects of molecular hydrogen on oxidative stress and related neurodegenerative diseases have been recently elucidated. Since reversing or preventing the oxidative damage and neuroinflammation induced by METH exposure might be useful in protecting against neuronal damage, molecular hydrogen may have a potential application in reducing the risk of neurodegeneration frequently observed in METH abusers.
Why These Findings Matter
These preclinical findings add evidence supporting molecular hydrogen's therapeutic potential within the outcomes and biological pathways measured in this model.
How Strong Is This Evidence?
This is preclinical animal evidence from a preclinical animal experiment. It is most informative for the disease model, mechanisms, biomarkers, and outcomes directly measured in the study.
Technical Study Details
H2HUBB classifies this publication as animal study with preclinical animal evidence. The research population or model was mice. The study used a preclinical animal experiment. The hydrogen delivery method was hydrogen-rich water. The source-reported hydrogen concentration was 2.0 mg/L H₂. The reported treatment duration was 7 days.
Limitations and Safety
Reported limitations: However, the lack of animal general condition record such as change of body weight after large dose of METH treatment was a limitation of this study.
Original Study and H2HUBB Research Context
H2HUBB presents this source-grounded research record as one contribution to the broader molecular-hydrogen evidence base.